Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Cardiology-CTVS
  • Cardiology & CTVS Perspective
  • Top Ten Landmark...

Top Ten Landmark Trials Across Cardiology - Dr Nihar Mehta

Written By : Dr Nihar Mehta |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2023-12-20T09:45:05+05:30  |  Updated On 20 Dec 2023 3:08 PM IST
Top Ten Landmark Trials Across Cardiology - Dr Nihar Mehta
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

1. Framingham Heart Study (1948):

The inception of modern cardiovascular epidemiology, the Framingham Heart Study, laid the foundation for understanding the risk factors associated with heart disease. It identified hypertension, high cholesterol, smoking, and diabetes as major contributors, guiding preventive strategies globally.

2. HOPE Trial (2000):

The Heart Outcomes Prevention Evaluation trial demonstrated the cardiovascular protective effects of angiotensin-converting enzyme (ACE) inhibitors. This landmark study influenced the use of ACE inhibitors in high-risk patients, emphasizing their role in preventing adverse cardiac events.

3. COURAGE Trial (2007):

Addressing the role of percutaneous coronary intervention (PCI) in stable coronary artery disease, the COURAGE trial challenged conventional wisdom by showing that optimal medical therapy alone was as effective as PCI in reducing major cardiovascular events.

4. TRITON-TIMI 38 (2007) and PLATO (2013):

In the TRITON-TIMI 38 trial, prasugrel exhibited significant efficacy advantages over clopidogrel, notably reducing the primary endpoint of cardiovascular death, MI, or stroke, and decreasing stent thrombosis.

In the PLATO trial, ticagrelor demonstrated superior efficacy over clopidogrel, significantly reducing the composite endpoint of vascular death, myocardial infarction (MI), or stroke.

The study confirmed consistent benefits across diverse patient groups and revealed a favourable safety profile for ticagrelor with no excess in major bleeding events emphasizing its potential as an alternative to clopidogrel in ACS management.

5. RE-LY Trial (2009):

Focused on stroke prevention in atrial fibrillation, the RE-LY trial introduced the novel oral anticoagulant dabigatran. Its findings revolutionized anticoagulation therapy, offering an alternative to traditional warfarin with improved safety and convenience.

6. The JUPITER trial (2012):

Revealed that rosuvastatin significantly reduces major cardiovascular events in apparently healthy individuals with LDL cholesterol <130 mg/dl but high-sensitivity C-reactive protein (hs-CRP) ≥2 mg/L. Despite an increased risk of diabetes in at-risk individuals, there was an overall net benefit, emphasizing the trial's significance.

7. PARADIGM-HF Trial (2014):

Shifting the paradigm in heart failure management, this trial demonstrated the superiority of sacubitril/valsartan over enalapril, heralding a new era in the treatment of heart failure with reduced ejection fraction.

8. The HOPE-3 trial (2016):

Revealed that low-dose statin therapy with rosuvastatin significantly reduces cardiovascular events in intermediate-risk individuals without known cardiovascular disease. Blood pressure lowering alone showed no overall benefit.

Combining cholesterol and blood pressure management demonstrated superior outcomes. The study supports the efficacy of low-dose statins in this population and emphasizes potential benefits of integrated lipid and blood pressure strategies.

9. ODYSSEY Outcomes Trial (2018):

Focused on the use of PCSK9 inhibitors, the ODYSSEY Outcomes trial provided crucial insights into the benefits of these agents in reducing recurrent cardiovascular events, opening new avenues for lipid-lowering therapy.

10. ISCHEMIA Trial (2019):

Examining the role of invasive strategies in managing stable ischemic heart disease, the ISCHEMIA trial questioned the routine use of revascularization procedures, emphasizing the importance of optimal medical therapy in certain patient populations.

11. PARTNER TRIALS:

The PARTNER trials, evaluating transcatheter aortic valve replacement (TAVR) against surgical aortic valve replacement (SAVR), revealed significant findings across risk categories.

In high-risk patients (PARTNER 1 -2010 ), TAVR proved noninferior to SAVR at 1 year, higher vascular complications but comparable 5-year outcomes, TAVI demonstrated improved outcomes, highlighting its efficacy for high-risk patients.

Intermediate-risk patients (PARTNER 2 - 2016) saw TAVR's noninferiority at 2 years, particularly in transfemoral cases, with sustained benefits at 5 years and cost-effectiveness.

For low-risk patients (PARTNER 3 - 2019), TAVR demonstrated superiority at 1 year, maintained over 5 years, showcasing lower stroke rates, reduced atrial fibrillation, and improved quality of life, all with cost-effectiveness. Ongoing research explores long-term implications.

Disclaimer: The views expressed in this article are of the author and not of Medical Dialogues. The Editorial/Content team of Medical Dialogues has not contributed to the writing/editing/packaging of this article.
cardiologylandmark trials in cardiologyten landmark trials across cardiologydr nihar mehtacardiology landmark trials
Dr Nihar Mehta
Dr Nihar Mehta

    Dr Nihar Mehta (MBBS, MD (Medicine), DNB (Medicine), DNB (Cardiology), Fellowship In Interventional Cardiology & Cardiovascular Imaging (South Korea)) is a Consultant Cardiologist and Associate Director (Department of Structural Heart Diseases) at Jaslok Hospital & Research Centre, Mumbai. He has over 19 years of experience in the field of Cardiology. His areas of expertise include Interventional Cardiology including Angiography, Angioplasty and Stenting, Cardiovascular Imaging, Cardiovascular Research, Transthoracic 2D Echocardiography, Transesophageal Echocardiography, StressTesting and Non-invasive Clinical Cardiology, Hypertension, Dyslipidemia and Preventive Cardiology.

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    View All

    Journal Club Today

    Global Omega-3 Shortage Poses Serious Health and Environmental Risks: Study

    Global Omega-3 Shortage Poses Serious Health and Environmental Risks: Study

    View All

    Health News Today

    Health Bulletin 31/May/2025

    Health Bulletin 31/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok